Moxifloxacin Tablet, Film Coated
Product Images NDC 33342-322

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Moxifloxacin (NDC 33342-322). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Blister Carton (Moxifloxacin 10x10s Carton)

Blister Carton (Moxifloxacin 10x10s Carton)
This text provides information about Moxifloxacin Tablets, USP manufactured by Macleods Pharma USA. The tablets contain 400 mg of moxifloxacin hydrochloride and are non-child resistant. It includes details such as batch number, expiration date, storage instructions, manufacturer's information, and dosage guidance. The pharmacist is advised to dispense these tablets with an accompanying Medication Guide for each patient.*
FDA Label Image

30s Count (Moxifloxacin 30s Container)

30s Count (Moxifloxacin 30s Container)
This text is a label for Moxifloxacin Tablets, which are used in the treatment of various bacterial infections. It specifies important details such as the dosage, storage instructions, manufacturer information, and precautions. The tablets contain 400 mg of moxifloxacin and should be kept at a controlled room temperature to maintain their efficacy. The medication should be dispensed with a Medication Guide and kept out of reach of children.*
FDA Label Image

Fig (Moxifloxacin Fig1)

FDA Label Image

Str (Moxifloxacin Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.